Remote methadone monitoring with a wearable patch
Part of Pain clinical trials.
This study tests a small patch that checks methadone levels in your sweat to make sure you're getting the right dose. It might help you and your doctor manage your treatment more easily from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You take methadone at a dose of 10 mg or more and have been taking it for at least one week
- You have taken your methadone as prescribed for the last 4 days
- You are not pregnant or planning to become pregnant during the study
- You do not have certain health conditions (like severe skin problems, anemia, or heart failure) that could interfere with the patch
- You are not currently enrolled in a substance use disorder treatment program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with chronic pain who take daily methadone. It aims to measure how much methadone is in your body to help doctors find the right dose.
This study is checking the levels of methadone and its breakdown products in your blood. It helps make sure the medication is working safely for conditions like opioid use disorder or chronic pain.
This study provides extra support to help people with heart failure who use methamphetamine to quit. The goal is to see if this support helps improve their heart health and overall well-being.
This study measures how methadone moves through your body by using planned blood samples and computer modeling. It may help doctors better predict methadone levels to support safer dosing for people already taking methadone.
This study tests if using a smartphone app to watch you take your methadone works as well as going to a clinic every day. It might make treatment easier for you.
This study uses a smartwatch to track wrist data and help detect when someone is using opioids or experiencing withdrawal. It's designed for people with opioid use disorder who are starting or already on treatment with methadone or buprenorphine.
Hear when a new Drug Metabolism, Poor, CYP2D6-Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.